Skip to main content
AbbVie Inc. logo

AbbVie Inc. — Investor Relations & Filings

Ticker · ABBV ISIN · US00287Y1091 LEI · FR5LCKFTG8054YNNRU85 US Manufacturing
Filings indexed 1,569 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country US United States of America
Listing US ABBV

About AbbVie Inc.

https://www.abbvie.com/

AbbVie Inc. is a global, research-based biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative medicines and therapeutic solutions. The company's mission is to address complex health issues and make a significant impact on patients' lives by combining advanced science with deep expertise. AbbVie develops treatments across various therapeutic areas, aiming to solve serious health challenges. In addition to its proprietary product pipeline, the company also offers contract manufacturing services for both small molecules and biologics, supporting other pharmaceutical partners in their development and production needs.

Recent filings

Filing Released Lang Actions
8-K - AbbVie Inc. (0001551152) (Filer)
Regulatory Filings
2026-05-12 English
10-Q - AbbVie Inc. (0001551152) (Filer)
Interim / Quarterly Report
2026-05-08 English
8-K - AbbVie Inc. (0001551152) (Filer)
Regulatory Filings
2026-04-29 English
8-K - AbbVie Inc. (0001551152) (Filer)
Regulatory Filings
2026-04-03 English
SCHEDULE 13G/A - AbbVie Inc. (0001551152) (Subject)
Major Shareholding Notification
2026-03-26 English
DEFA14A - AbbVie Inc. (0001551152) (Filer)
Regulatory Filings
2026-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.